MGC Pharmaceuticals (ASX:MXC) share price rockets 40% on supply deal

A new US supply and distribution deal has seen shares in the pharma company soar

| More on:
A businessman leaps in the air outside a city building in the CBD.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has bolted more than 40% higher in morning trade today.   

Investors are bidding shares in the pharmaceutical company higher after it released an announcement earlier today. At the time of writing, MGC shares are swapping hands for 5.5 cents, up 41%.

Let's take a look at what MGC Pharmaceuticals announced.

MGC Pharma share price bolts on US supply agreement

Earlier today, MGC Pharma informed shareholders the company has entered a binding, 3-year US supply and distribution agreement.

The agreement with US-based company, AMC Holdings Inc (AMC), includes a minimum supply order of US$24million.

A range of MGC's phytomedicine products is included in the agreement, namely; CannEpil, CogniCann, and CimetrA.

Under the agreement, AMC will act as a licenced distributor and undertake all marketing activities in the US. In addition, the company will also manage the importing and warehousing of MGC Pharma's products.

In addition to supply, AMC will also be responsible for coordinating relevant clinical trial processes for MGC Pharma's products.  

The agreement also outlines a minimum US$3 million of sales in Year 1.

Additionally, MGC Pharma can terminate the agreement if AMC fails to secure regulatory approval for at least 1 of the listed MGC products by 30 September 2021.

What did management say?

MGC Pharmaceuticals' management highlighted the importance of the company's milestone of expanding into the US. 

Co-founder and managing director Roby Zomer commented:

This is an important milestone agreement for MGC Pharma, as it provides MGC access to the largest healthcare market in the world. We look forward to working with our new partners at AMC and utilising their expertise and network to widen patient access to MGC's phytomedicine products.

Snapshot of the MGC Pharmaceuticals share price

The MGC Pharma share price has had an extremely volatile year thus far. Shares in the company bolted to record highs earlier in the year after listing on the London Stock Exchange (LSE).

Since then, the MGC Pharmaceuticals share price has whittled away from its highs throughout the year.

At the time of writing, MGC shares are trading 41% higher for the day. The MGC Pharmaceuticals share price was up more than 50% earlier today, after hitting an intra-day high of 6 cents per share.

Including today's bullish price action, shares in MGC are trading around 118% higher year to date.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

piggy bank at end of winding road
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors enjoyed a lucrative Tuesday session today.

Read more »

A hipster-looking man with bushy beard and multiple arm tattoos sits on the floor against a sofa reading a tablet with his hand on his chin as though he is deep in thought.
Share Market News

ASX 200 dips on RBA interest rate decision

The ASX 200 gave up some of its intraday gains following the latest RBA interest rate announcement. But why?

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Capitol Health, Infratil, Newmont, and Race Oncology shares are charging higher

These shares are having a good session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Beach Energy, Fortescue, Kina Securities, and Melbana Energy shares are dropping today

These shares are missing out on the good times today. But why?

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
52-Week Highs

CBA, DroneShield, and these ASX stocks just hit 52-week highs

These shares are flying high on Tuesday. What's going on?

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

Macquarie shares have 10% upside: Morgan Stanley

Another bullish broker on Macquarie.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Broker Notes

Is the ANZ share price 'the best value of the major banks'?

ANZ shares are in the green today.

Read more »

Two kids in superhero capes.
Small Cap Shares

2 ASX small-cap shares I'd buy for massive growth potential

I’m bullish about these two stocks.

Read more »